** Drugmaker Alkermes shares ALKS.O rise 8.5% to $30.4
** Co reports revenue of $377.5 million vs estimates of $362
mln - LSEG data
** ALKS expects to record sales of $1.5 billion to $1.6
billion in 2024 vs estimates were $1.52 bln
** Q4 profit was 22 cents per share, below estimates of 51
cents per share
** Co's board approved a new share repurchase program of up
to $400 mln
** As of Dec. 31, co recorded cash, cash equivalents of
$813.4 mln vs $740.1 mln last year
** Including session gains, stock had risen ~12% in lat 12
months
(Reporting by Khushi Mandowara in Bengaluru)
((Khushi.Mandowara@thomsonreuters.com;))